Science 37 is a publicly traded pioneer in decentralized clinical trials, which offers an end-to-end 'operating' system for trial sponsors and CROs. The company leverages its various networks to enable hybrid and fully decentralized trials. The decentralized model also helps foster diversity and inclusion, which has become an important selling point.